PTAC Postdoctoral Research Fellowship Award supports postdoctoral researchers in mentored basic science to advance therapies that restore CFTR function or repair or replace the defective gene.
Funder: Cystic Fibrosis Foundation
Due Dates: May 12, 2026 (Application) | December 8, 2026 (Fall application, 5 p.m. Eastern)
Funding Amounts: Up to $75,000 in Year 1 and $76,000 in Year 2; up to two years; no indirect costs
Summary: Supports mentored postdoctoral basic-science training to advance therapies that restore CFTR function or repair or replace the defective CFTR gene.
Key Information: Candidates must be U.S. citizens, permanent residents, or non-residents working in a U.S.-based laboratory.
The Cystic Fibrosis Foundation’s Path to a Cure (PTAC) Postdoctoral Research Fellowship supports research training in new areas and methods, helping fellows build scientific knowledge, collect data, and prepare for independent research careers. Projects should generate information contributing to therapies that repair or replace CFTR variants not served by existing small-molecule modulators.
The program funds foundational concepts, strategies, tools, methods, and technologies with potential to restore CFTR protein function or fix the defective gene. Its broader goal is effective CFTR-directed treatment for all people with cystic fibrosis, including those whose mutations resist modulators, produce insufficient protein, or prevent protein synthesis, and people unable to tolerate or take approved modulators.